← SynDRA
BMS-345541
SynDRA canonical compound SYN0007848 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | IKBKB |
|---|
| Mechanism of action | IKK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- IKK inhibitor
- CHUK NEGATIVE ALLOSTERIC MODULATOR
- IKBKB NEGATIVE ALLOSTERIC MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CDK7
- MYLK4
- CDK13
- CDK11B
- CDK11A
- MAP3K19
- AAK1
- PDGFRB
- PIK3CA
- PIK3C2G
- PIK3C2B
- PI4KB
- PHKG2
- PHKG1
- PDPK1
- PAK5
- PDGFRA
- PAK6
- PIK3CD
- PAK4
- PAK3
- PAK2
- PAK1
- OXSR1
- OGG1
- NUAK2
- PIK3CB
- PIK3CG
- NTRK3
- PLK3
- PRKCH
- PRKCE
- PRKCD
- PRKCA
- PRKACB
- PRKACA
- PRKAA2
- PRKAA1
- POLK
- PLK4
Cross-references
Synonyms
- BMS345541
- BMS-345541 free base
- BMS-345541 (free base)
- UNII-26SU0NEF5F
- N1-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)ethane-1,2-diamine
- 26SU0NEF5F
- IKK Inhibitor III, BMS-345541
- C14H17N5
- 4-(2&
- -Aminoethyl)amino-1,8-dimethylimidazo[1,2-a]quinoxaline
- BMS-345541(free base)
- IKK Inhibitor III
- Kinome_3215
- SCHEMBL118886
- GTPL5669
- CHEMBL249697
- CTK8E9618
- KS-00001CRN
- CHEBI:91340
- BDBM25919
- DTXSID60196216
- PSPFQEBFYXJZEV-UHFFFAOYSA-N
- MolPort-035-395-836
- HMS3653F06
- HMS2043P05
- 4(2'-Aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline
- RefChem:911785
- BMS345541 (free base)
- orb1300867
- SCHEMBL29670419
- GLXC-08077
- EX-A2033
- VSA43058
- BDBM50353371
- MFCD18089812
- AKOS027301564
- CCG-267014
- CS-1238
- NCGC00165761-01
Look up BMS-345541 in the interactive SynDRA portal →